Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
iTeos Therapeutics, Inc. (ITOS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 34,846 shares
@ $14.19, valued at
$494.5k
Sold 95,516 shares
@ $15.63, valued at
$1.5M
Sold 219,638 shares
@ $16.87, valued at
$3.7M
|
|
| 06/15/2023 |
4
| Van Hauwermeiren Timothy (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/15/2023 |
4
| RHOADS ANN D (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/15/2023 |
4
| Iannone Robert (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/15/2023 |
4
| Ho Tony W (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/15/2023 |
4
| Hallal David (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/15/2023 |
4
| DiRocco Derek (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/15/2023 |
4
| Davis Aaron I. (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2023 |
4
| McGrath Yvonne (Chief Scientific Officer) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $16.66, valued at
$2.2M
|
|
| 03/10/2023 |
4
| Lager Joanne Jenkins (Chief Medical Officer) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $16.66, valued at
$2.2M
|
|
| 03/10/2023 |
4
| Gall Matthew (CFO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $16.66, valued at
$2.2M
|
|
| 03/10/2023 |
4
| Call Matthew (COO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $16.66, valued at
$2.2M
|
|
| 03/10/2023 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 346,000 options to buy
@ $16.66, valued at
$5.8M
Gifted 254,997 options to buy
@ $16.66, valued at
$4.2M
Gifted 254,997 options to buy
@ $16.66, valued at
$4.2M
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Van Hauwermeiren Timothy (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 17,538 options to buy
@ $18.78, valued at
$329.4k
|
|
| 06/10/2022 |
4
| RODEN MATTHEW (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 17,538 options to buy
@ $18.78, valued at
$329.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Biniszkiewicz Detlev (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 17,538 options to buy
@ $18.78, valued at
$329.4k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 11,467 shares
@ $31.87, valued at
$365.5k
Sold 33 shares
@ $32.64, valued at
$1.1k
Exercised 11,500 options to buy
@ $4.23, valued at
$48.6k
|
|
| 03/24/2022 |
4
| Davis Aaron I. (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Bought 21,300 shares
@ $31.875, valued at
$678.9k
Bought 3,700 shares
@ $33.0898, valued at
$122.4k
Bought 5,000 shares
@ $33.4278, valued at
$167.1k
Bought 20,000 shares
@ $32.849, valued at
$657k
|
|
| 03/22/2022 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 5,822 shares
@ $33.44, valued at
$194.7k
Sold 9,908 shares
@ $34.11, valued at
$338k
Sold 1,159 shares
@ $35.22, valued at
$40.8k
Sold 1,548 shares
@ $36.51, valued at
$56.5k
|
|
| 03/18/2022 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 575,201 shares
@ $35.25, valued at
$20.3M
|
|
| 03/14/2022 |
4
| McGrath Yvonne (Chief Scientific Officer) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $36.21, valued at
$3.1M
|
|
| 03/14/2022 |
4
| Lager Joanne Jenkins (Chief Medical Officer) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $36.01, valued at
$126k
Granted 85,000 options to buy
@ $36.21, valued at
$3.1M
Exercised 3,500 options to buy
@ $4.3, valued at
$15.1k
|
|
| 03/14/2022 |
4
| Gall Matthew (CFO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $36.21, valued at
$3.1M
|
|
|
|
|